You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

capecitabine

Showing 1 - 25 of 1,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)

Not yet recruiting
  • Recurrent Metastatic Nasopharyngeal Carcinoma
  • Mitoxantrone hydrochloride liposome injection
  • Capecitabine
  • (no location specified)
Jan 29, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Mitoxantrone hydrochloride liposome
  • Capecitabine
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)

Not yet recruiting
  • Pancreas Cancer
  • Pancreas Adenocarcinoma
  • Capecitabine
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)

Not yet recruiting
  • Gastrointestinal Cancer
  • Capecitabine
  • Sacituzumab govetican
  • (no location specified)
Oct 2, 2023

Colorectal Cancer, Colorectal Cancer Stage IV Trial (Fruquintinib Plus Capecitabine, Capecitabine)

Not yet recruiting
  • Colorectal Cancer
  • Colorectal Cancer Stage IV
  • Fruquintinib Plus Capecitabine
  • Capecitabine
  • (no location specified)
Jul 9, 2022

HER2 Positive Metastatic Breast Cancer Trial in Beijing (pyrotinib, , Capecitabine)

Active, not recruiting
  • HER2 Positive Metastatic Breast Cancer
  • Beijing, China
    307 Hospital Affiliated to Academy Military Medical Science
Oct 24, 2022

Advanced Gastric Carcinoma Trial in Dhaka (Trastuzumab, Oxaliplatin, Capecitabine)

Completed
  • Advanced Gastric Carcinoma
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Aug 15, 2023

Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Breast, Metastatic, Triple Negative Trial in Gainesville, Jacksonville (Capecitabine, Sarilumab 150mg or 200 mg plus

Active, not recruiting
  • Breast
  • +4 more
  • Capecitabine
  • +2 more
  • Gainesville, Florida
  • +1 more
Feb 2, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-yat sen university cancer center
Nov 1, 2022

Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China

Recruiting
  • Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
  • Benowa, Queensland, Australia
  • +7 more
Jan 30, 2023

Recurrent Pituitary Adenomas Trial in New York (Capecitabine, Temozolomide)

Terminated
Has Results
  • Recurrent Pituitary Adenomas
  • New York, New York
    Weill Cornell Medical College
Jul 15, 2022

Gastric Adenocarcinoma, Gastric Cancer, Esophagogastric Junction Trial run by the NCI (Paclitaxel, Capecitabine, BardPort

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

Active, not recruiting
  • Breast Cancer
  • Capecitabine
  • Aromatase Inhibitor
  • Guangzhou, Guangdong, China
    State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))

Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Capecitabine
  • PD-1 Antibody（Tislelizumab）
  • Shanghai, China
    Lulu@Huashan.Org.Cn
Aug 16, 2022

Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)

Recruiting
  • Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Nov 1, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HER2-positive Breast Cancer Trial (Margetuximab, Tucatinib, Capecitabine)

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • (no location specified)
Jul 6, 2022

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023